Fig. 2From: Development and validation of the comprehensive assessment scale for chemotherapy–induced peripheral neuropathy in survivors of cancerThe relationship patient-reported CAS-CIPN and nurse- reported CTCAE (Peripheral sensory neuropathy). **Significant difference between groups (p < 0.01). CAS-CIPN: Comprehensive Assessment Scale for Chemotherapy-Induced Peripheral Neuropathy in Survivors of Cancer; CTCAE: Common Terminology Criteria for Adverse EventsBack to article page